Clinical Trial Update: Prevention of Silent Cerebral Thromboembolism by Oral Anticoagulation With Dabigatran After Pulmonary Vein Isolation for Atrial Fibrillation [Phase 4]

View source ↗

Summary

A Phase 4 trial investigated whether dabigatran oral anticoagulation after pulsed vein isolation reduces silent cerebral thromboembolism in patients with atrial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Dabigatran (Dabigatran etexilate)

Snippet

Sponsor: Georg Nickenig | Conditions: Atrial Fibrillation, Cardioembolic Events | Phase 4 | Status: COMPLETED